Leap Therapeutics
Leap Therapeutics50About
What does Leap Therapeutics do?
Leap Therapeutics is a biopharmaceutical company dedicated to developing and commercializing targeted and immuno-oncology therapies for patients with cancer. Their pipeline includes several promising drug candidates, with a primary focus on agents that modulate the tumor microenvironment and enhance the body's immune response against cancer cells.
What is Leap Therapeutics's revenue?
StartupHub estimates Leap Therapeutics's annual revenue at $13.7M (range $6.3M to $186.4M, 30% confidence), based on comparable companies in the sector.
What is Leap Therapeutics's valuation?
StartupHub estimates Leap Therapeutics's effective valuation at $725.8M (range $472.5M to $1.1B, 19% confidence), based on comparable companies in the sector.
How much funding has Leap Therapeutics raised?
Leap Therapeutics has raised a total of $189M in funding. The most recent round on record is Series C.
Where is Leap Therapeutics headquartered?
Leap Therapeutics is headquartered in Cambridge, United States.
When was Leap Therapeutics founded?
Leap Therapeutics was founded in 2017.
What industry does Leap Therapeutics operate in?
Leap Therapeutics operates in Biotech, HealthTech, Drug Discovery, Clinical Trials, Oncology, Immuno-oncology.
What is Leap Therapeutics's current status?
Leap Therapeutics's current operating status is: Inactive.
No comments yet. Be the first to share your take.